A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

August 19, 2026

Study Completion Date

November 19, 2026

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

Standard of Care

Standard of Care (SOC) includes, but is not limited to, surgical debridement, aggressive infection management, offloading, and maintenance of appropriate cleansing at the time of each dressing change.

DEVICE

PuraPly AM

PuraPly Antimicrobial Wound Matrix is a 2-layer cross-linked extracellular matrix (PCMP) scaffolding that consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride (PHMB)

DEVICE

PuraPly XT

PuraPly Antimicrobial XT Wound Matrix is a 5- layer cross-linked extracellular matrix (PCMP) scaffolding that consists of a collagen sheet coated with 0.1% polyhexamethylenebiguanide hydrochloride (PHMB)

Trial Locations (1)

44103

RECRUITING

Kent State University, College of Podiatric Medicine, Clevland

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Serena Group

OTHER

lead

Organogenesis

INDUSTRY

NCT06618612 - A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter